317 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Acquired by Values First Advisors Inc.

Values First Advisors Inc. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 317 shares of the financial services provider’s stock, valued at approximately $43,000.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Good Life Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at about $217,000. WealthCare Investment Partners LLC increased its stake in iShares Biotechnology ETF by 3.9% in the 4th quarter. WealthCare Investment Partners LLC now owns 9,043 shares of the financial services provider’s stock worth $1,261,000 after purchasing an additional 343 shares in the last quarter. WASHINGTON TRUST Co increased its stake in iShares Biotechnology ETF by 212.0% in the 4th quarter. WASHINGTON TRUST Co now owns 596 shares of the financial services provider’s stock worth $81,000 after purchasing an additional 405 shares in the last quarter. First National Corp MA ADV increased its stake in iShares Biotechnology ETF by 6.9% in the 4th quarter. First National Corp MA ADV now owns 15,159 shares of the financial services provider’s stock worth $2,059,000 after purchasing an additional 978 shares in the last quarter. Finally, PFG Investments LLC grew its stake in iShares Biotechnology ETF by 118.4% during the 4th quarter. PFG Investments LLC now owns 4,397 shares of the financial services provider’s stock valued at $597,000 after acquiring an additional 2,384 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.4 %

Shares of NASDAQ IBB traded down $0.57 during trading hours on Thursday, hitting $137.22. The stock had a trading volume of 1,441,164 shares, compared to its average volume of 1,868,127. The firm’s 50-day moving average price is $136.42 and its two-hundred day moving average price is $128.75. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.37%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.